Digital Health Startups

nen builds digital programs that use interactive games and play to teach children behavioral techniques for managing pain, with a focus on pediatric cancer patients. Its offerings serve kids, their families, and healthcare professionals in the pediatric pain and wellbeing space.

1 investor

NeoGenomics develops diagnostic tests and tools for cancer care, including tests for immunotherapy response monitoring, therapy selection, and minimal residual disease detection.

1 investor

Neomed is a Brazilian healthtech that combines artificial intelligence with cardiologists to speed cardiovascular diagnosis, offering AI-based ECG triage and remote reporting of graphic-method exams for hospitals, emergency rooms, clinics, and labs. It reports serving over 1,500 health institutions across all regions of Brazil.

1 investor

Nephris is a biotech company developing first-in-class therapies for diabetic chronic kidney disease. It focuses on research and innovation for patients with diabetic renal disease.

1 investor

NeraCare develops clinically validated prognostic tests that personalize survival prediction and risk stratification for patients with early-stage melanoma, guiding adjuvant therapy decisions. The company operates as a partnership-driven diagnostics firm supporting clinical studies and collaborations across Europe and the U.S.

1 investor

Neru Health provides an AI platform, Nora, that automates patient onboarding, therapy adherence monitoring, resupply optimization, and EHR/data management for durable medical equipment (DME) providers. It integrates with DME software, scheduling systems, and phone trees to reduce operating costs, improve Medicare/PAP compliance, and route exceptions to clinical and resupply teams.

1 investor

Nerveli develops digital support for people managing chronic pain, providing science-backed daily guidance between medical appointments through understanding pain mechanisms and nervous system responses. The platform is designed for chronic pain patients and works alongside healthcare providers.

1 investor

Netmeds.com is an Indian online pharmacy that sells prescription medicines, OTC products, wellness items, and health supplements with home delivery across India, including smaller cities and rural areas. It also offers generic alternatives, drug information, and refill reminders for consumers managing chronic and everyday health needs.

1 investor

Netta is a web application providing free PDF editing tools including merging, splitting, compression, conversion, rotation, unlocking, and watermarking. The platform serves general users seeking to manage and edit PDF documents online.

1 investor

Neuemoon is a health platform built to support young girls and women in understanding menstrual health and accessing information about conditions like endometriosis and fibroids. The company aims to help women recognize abnormal symptoms and connect with appropriate medical care earlier than traditional pathways.

1 investor

Neumarker develops machine learning and biophysical tools to advance neuropsychiatric drug development and clinical care for CNS disorders. The company serves pharmaceutical and clinical organizations working on psychiatric and neurological treatments.

1 investor

NeurAbilities Healthcare provides diagnostic and therapeutic services for patients with neurological and developmental conditions, combining precision medicine, behavioral sciences, and therapeutic treatments. It serves patients seeking neurological and behavioral healthcare.

1 investor

Neuralert develops a patented algorithm and wearable technology aimed at early stroke detection. The company operates in the medical device and digital health space, with ties to University of Pennsylvania neurology research.

1 investor

eNeura develops single-pulse transcranial magnetic stimulation (sTMS) neuromodulation devices for the acute and preventive treatment of migraine. Its products are used by patients, including veterans through the VA, and prescribed by healthcare providers, with operations in the US and UK.

1 investor

NeuraVue provides AI-powered monitoring systems for senior care facilities and independent living settings, detecting falls, wandering, and distress to alert caregivers and family members in real time. The platform serves independent living communities, assisted living facilities, skilled nursing homes, and aging-in-place scenarios, with specialized capabilities for dementia care.

1 investor

NeurAxis develops neuromodulation therapies targeting the gut-brain axis for patients with disorders of gut-brain interaction, such as functional abdominal pain associated with irritable bowel syndrome and functional dyspepsia. Its lead device delivers drug-free, non-surgical nerve stimulation for pediatric and adult patients.

1 investor

NeurekaLab is a digital educational app for children ages 5-12 that uses gamification and personalized activities to improve reading, mathematics, attention, and memory. It serves schools, families, and health professionals with scientifically-validated tools for assessment and learning support.

1 investor

NeuroAge offers multi-modal brain health testing that combines cognitive games, volumetric MRI, whole-genome sequencing, and blood biomarker tests to measure "brain age" and dementia risk for individuals concerned about neurodegenerative disease. It provides a unified dashboard, personalized recommendations, and brain training aimed at early detection of Alzheimer's and cognitive decline.

1 investor

NeuroChat is a brain-computer interface platform that lets people with severe motor and speech impairments (cerebral palsy, ALS, stroke, multiple sclerosis, neurotrauma) type text and communicate through mental effort, with built-in online translation between languages. It also serves as a neurotraining system for developing cognitive functions such as attention, memory, and reaction speed by analyzing EEG data via a hardware headset and software interface.</parameter> <parameter name="founders">[{"full_name": "Наталия Галкина", "title": "Генеральный директор (CEO)"}, {"full_name": "Александр Лужин", "title": "Руководитель НИОКР НейроЧат"}, {"full_name": "Алеся Чичинкина", "title": "Директор по коммуникациям и международному развитию"}, {"full_name": "Юрий Мустафин", "title": "Технический директор (CTO)"}, {"full_name": "Александр Каплан", "title": "Научный руководитель проекта"}, {"full_name": "Игорь Зимин", "title": "Директор по развитию бизнеса"}, {"full_name": "Галина Ершова", "title": "Руководитель патронажной службы"}]

1 investor

NeuroDex develops blood-based biomarkers and diagnostic assays for neurological diseases, including rare genetic disorders, Parkinson's disease, Alzheimer's disease, and ALS. The company works with biopharmaceutical companies to enable patient selection, treatment monitoring, and accelerated disease diagnosis in clinical development programs.

1 investor

NeuroEquilibrium operates a network of clinics specializing in diagnosis and treatment of vertigo, dizziness, and balance disorders through a deep-tech platform that integrates cloud technology, computer vision, and remote diagnostics. The company serves patients and healthcare providers in India and globally, aiming to standardize care for vestibular disorders.

1 investor

Neurofit is a web-based cognitive rehabilitation platform that enables clinicians to assign adaptive cognitive activities, track client performance data, and generate clinical reports for insurance claims. It serves occupational therapists, speech-language pathologists, neuropsychologists, and rehabilitation medicine professionals treating clients across the lifespan.

1 investor

NeuroGevity develops a sleep headband with biometric sensors and AI algorithms to assess brain health and detect neurophysiological biomarkers at home. The company also offers sound-based stimulation synchronized to brain activity to enhance slow-wave sleep and memory consolidation.

1 investor

NeuroRehab VR offers Smart Therapy, a portable VR-based rehabilitation solution for treating upper and lower extremity dysfunction, chronic pain, anxiety, cognition, and balance across orthopedic, neurological, and wellness settings. The platform includes AI-powered documentation features and is designed for clinicians in various care environments.

1 investor